멕실레틴

용도

• Treating or assisting in treatment of ventricular arrhythmias
• Treating or assisting in treatment of ventricular arrhythmias
• Ventricular arrhythmias in Boxers
• Treating or assisting in treatment of ventricular arrhythmias
• Familial arrhythmic cardiomyopathy of Boxers (ARVC)
• Treating or assisting in treatment of ventricular arrhythmias
• Myotonia congenita or myokymia

투여 방법

가능한 부작용

• Vomiting (very common)
• Nausea
• Trembling/Tremors
• Unsteadiness/Ataxia
• Dizziness
• Depression/Lethargy
• Shortness of breath
• Proarrhythmia (PVCs)
• Chest pain
• Seizures (rare)
• Agranulocytosis (rare)
• Thrombocytopenia (rare)

주의사항 및 금기

• Pre-existing 2nd or 3rd degree AV block (without a pacemaker)
• Cardiogenic shock
• Known hypersensitivity to mexiletine
• Use with **extreme caution** in patients with severe congestive heart failure, acute myocardial infarction, hepatic function impairment, hypotension, intraventricular conduction abnormalities, sinus node function impairment, or a pre-existing seizure disorder. > **Clinical Note**: Mexiletine is secreted into maternal milk; use of a milk replacer is recommended if the nursing mother is receiving the drug. FDA Pregnancy Category C.

약물 상호작용

• Antacids (Aluminum-Magnesium): May slow the absorption of mexiletine.
• Atropine: May reduce the rate of oral absorption.
• Cimetidine: May increase or decrease mexiletine blood levels.
• Griseofulvin: May accelerate the metabolism of mexiletine.
• Lidocaine: May cause additive adverse effects (especially CNS toxicity).
• Metoclopramide: May accelerate the absorption of mexiletine.
• Opiates: May slow the absorption of mexiletine.
• Phenobarbital: May accelerate the metabolism of mexiletine.
• Primidone: May accelerate the metabolism of mexiletine.
• Phenytoin: May accelerate the metabolism of mexiletine.
• Rifampin: May accelerate the metabolism of mexiletine.
• Theophylline: Mexiletine may reduce the metabolism of theophylline, potentially leading to theophylline toxicity.

자주 묻는 질문